Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Oncology/Epidemiology
  • Published:

Clinical Oncology/Epidemiology

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix

British Journal of Cancer volume 56, pages 157–158 (1987)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Division of Gynaecology, Netherlands Cancer Institute, Amsterdam

    G Kenter

Authors
  1. G Kenter
    View author publications

    Search author on:PubMed Google Scholar

  2. JMG Bonfrer
    View author publications

    Search author on:PubMed Google Scholar

  3. APM Heintz
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kenter, G., Bonfrer, J. & Heintz, A. Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix. Br J Cancer 56, 157–158 (1987). https://doi.org/10.1038/bjc.1987.176

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/bjc.1987.176

This article is cited by

Search

Advanced search

Quick links